Chinese Journal of Integrative Medicine

, Volume 20, Issue 2, pp 83–87 | Cite as

Cure for acquired immunodeficiency syndrome—A global battle

  • Jie Wang
Feature Article


Human Immunodeficiency Virus Human Immunodeficiency Virus Infection Unprotected Sexual Activity Integrase Inhibitor Elvitegravir 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    WHO/UNAIDS. AIDS epidemic update 2004. Scholar
  2. 2.
    Wayne CK, Berkley SF. The renaissance in HIV vaccine development—future directions. N Engl J Med 2010;363:e7.PubMedCrossRefGoogle Scholar
  3. 3.
    Kvitsinadze L, Tvildiani D, Pkhakadze G. HIV/AIDS prevalence in the southern caucasus. Georgian Med News 2010;189:26–36.PubMedGoogle Scholar
  4. 4.
    Jansen IA, Geskus RB, Davidovich U, Jurriaans S, Coutinho RA, Prins M, et al. Ongoing HIV-1 transmission among men who have sex with men in Amsterdam: a 25-year prospective cohort study. AIDS 2011;25:493–501.PubMedCrossRefGoogle Scholar
  5. 5.
    Zhang YH, Bao YG, Sun JP, Tan HZ. Analysis of HIV/Syphilis/HCV infection among drug users in 15 cities, China. Chin J Prevent Med (Chin) 2010;44:969–974.Google Scholar
  6. 6.
    Lei N, Peng ZH, Huan XP, Chen X, Yu RB, Yang HT. Estimation and prediction of the epidemic situation of acquired immunodeficiency syndrome in Jiangsu province. Chin J Prevent Med (Chin). 2010;44:1012–1017.Google Scholar
  7. 7.
    Jia M, Luo H, Ma Y, Wang N, Smith K, Mei J, et al. The HIV epidemic in Yunnan Province, China, 1989–2007. J Acquir Immune Defic Syndr 2010;53(Suppl 1):S34–S40.PubMedCrossRefGoogle Scholar
  8. 8.
    Mildvan D, Mathur U, Enlow RW, Romain PL, Winchester RJ, Colp C, et al. Opportunistic infections and immune def iciency in homosexual men. Ann Intern Med 1982;96:700–704.PubMedCrossRefGoogle Scholar
  9. 9.
    Vilcek J. Boosting p53 with interferon and viruses. Nat Immunol 2003;4:825–826.PubMedCrossRefGoogle Scholar
  10. 10.
    Piacentini L, Biasin M, Fenizia C, Clerici M. Genetic correlates of protection against HIV infection: the ally within. J Intern Med 2008;265:110–124.CrossRefGoogle Scholar
  11. 11.
    Boasso A, Shearer GM, Chougnet C. Immune dysregulation in human immunodeficiency virus infection: know it, fix it, prevent it? J Intern Med 2009;265:78–96.PubMedCentralPubMedCrossRefGoogle Scholar
  12. 12.
    Rerks-Ngarm S, Pitisuttithum P, Nitayaphan S, Kaewkungwal J, Chiu J, Paris R. et al. Vaccination with ALVAC and AIDSVAX to prevent HIV-1 infection in Thailand. N Engl J Med 2009;361:2209–2220.PubMedCrossRefGoogle Scholar
  13. 13.
    Alcaro S, Alteri C, Artese A, Ceccherini-Silberstein F, Costa G, Ortuso F, et al. Molecular and structural aspects of clinically relevant mutations related to the approved nonnucleoside inhibitors of HIV-1 reverse transcriptase. Drug Resist Updat 2011;14:141–149.PubMedCrossRefGoogle Scholar
  14. 14.
    Al-Mawsawi LQ, Neamati N. Al loster ic Inhibi tor development targeting HIV-1 integrase. Chem Med Chem 2011;6:228–241.PubMedCentralPubMedCrossRefGoogle Scholar
  15. 15.
    Rhame FS. When to start antiretroviral therapy. Curr Infect Dis Rep 2011;13:60–67.PubMedCrossRefGoogle Scholar
  16. 16.
    Wang J, Lin HS, Liu MY, Li Y. Immune reconstitution of acquired immune deficiency syndrome. Chin J Integr Med 2010;16:557–64.PubMedCrossRefGoogle Scholar
  17. 17.
    Luo SD, Fan DQ, Wang HY, eds. Activity of herbal meidicine in anti-HIV: Kunming: Yunnan Scientific and Technology Publishing House; 1998:6.Google Scholar
  18. 18.
    Xu HX, Wan M, Loh BN, Kon OL, Chow PW, Sim KY. Screening of traditional medicines for their inhibitory activity against HIV-1 protease. Phytotherapy Res 1996;10:207–210.CrossRefGoogle Scholar
  19. 19.
    Ma BY, Fu LC, Chen XJ. Progress of single and compound herbal medicine in anti-HIV. Tradit Chin Med Inform (Chin) 2007;24:17–20.Google Scholar
  20. 20.
    Guan CF, Wang J, Xu SL. Clinical and experiment studies on Zhongyan II in HIV/A1DS treatment. Chin J Integr Tradit West Med (Chin) 2003;23:494–497.Google Scholar
  21. 21.
    Guo HJ, Liu XW, Wang DN. The effects of Fuzheng Paidu I in treating asymptomatic HIV infection. Shanghai Tradit Chin Med (Chin) 2006;40:20–21.Google Scholar
  22. 22.
    Peng B, Wang DN. Clinical observation on 65 cases of asymptomatic HIV infection treated by Fuzheng PaiduII. J Tradit Chin Med (Chin) 2006;24:1781–1783.Google Scholar

Copyright information

© Chinese Association of the Integration of Traditional and Western Medicine and Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  1. 1.Guang’anmen HospitalChina Academy of Chinese Medical SciencesBeijingChina

Personalised recommendations